Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 4/2015

01-12-2015

Comorbid condition care quality in cancer survivors: role of primary care and specialty providers and care coordination

Authors: Claire F. Snyder, Kevin D. Frick, Robert J. Herbert, Amanda L. Blackford, Bridget A. Neville, Klaus W. Lemke, Michael A. Carducci, Antonio C. Wolff, Craig C. Earle

Published in: Journal of Cancer Survivorship | Issue 4/2015

Login to get access

Abstract

Purpose

The purpose of this study is to investigate provider specialty, care coordination, and cancer survivors’ comorbid condition care.

Methods

This retrospective cross-sectional Surveillance, Epidemiology, and End Results (SEER)-Medicare study included cancer survivors diagnosed in 2004, 2–3 years post-cancer diagnosis, in fee-for-service Medicare. We examined (1) provider specialties (primary care providers (PCPs), oncology specialists, other specialists) visited post-hospitalization, (2) role of provider specialties in chronic and acute condition management, and (3) an ambulatory care coordination measure. Outcome measures covered (1) visits post-hospitalization for nine conditions, (2) chronic disease management (lipid profile, diabetic eye exam, diabetic monitoring), and (3) acute condition management (electrocardiogram (EKG) for congestive heart failure (CHF), imaging for CHF, EKG for transient ischemic attack, cholecystectomy, hip fracture repair).

Results

Among 8661 cancer survivors, patients were more likely to visit PCPs than oncologists or other specialists following hospitalizations for 8/9 conditions. Patients visiting a PCP (vs. not) were more likely to receive recommended care for 3/3 chronic and 1/5 acute condition indicators. Patients visiting a nother specialist (vs. not) were more likely to receive recommended care for 3/3 chronic and 2/5 acute condition indicators. Patients visiting an oncology specialist (vs. not) were more likely to receive recommended care on 2/3 chronic indicators and less likely to receive recommended care on 1/5 acute indicators. Patients at greatest risk for poor coordination were more likely to receive appropriate care on 4/6 indicators.

Conclusions

PCPs are central to cancer survivors’ non-cancer comorbid condition care quality.
Implications for Cancer Survivors
PCP involvement in cancer survivors’ care should be promoted.
Literature
1.
American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2012–2013. Atlanta, GA: American Cancer Society; 2012.
2.
Rowland JH, Mariotto A, Alfano CM, Pollack LA, Weir HK, White A. Cancer survivors—United States, 2007. MMWR. 2011;60:269–72.
3.
Institute of Medicine. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academy Press; 2006.
4.
Armes J, Crowe M, Colbourne L, et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009 20;27:6172–9.
5.
Aaronson NK, Mattioli V, Minton O, et al. Beyond treatment—psychosocial and behavioural issues in cancer survivorship research and practice. Eur J Cancer Suppl. 2014;12:54–64.CrossRef
6.
Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447–51.CrossRefPubMed
7.
Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101:1712–9.CrossRefPubMed
8.
Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med. 2008;23:254–9.PubMedCentralCrossRefPubMed
9.
Snyder CF, Frick KD, Peairs KS, et al. Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med. 2009;24:469–74.PubMedCentralCrossRefPubMed
10.
Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol. 2008;26:1073–9.CrossRefPubMed
11.
Snyder CF, Frick KD, Kantsiper ME, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27:1054–61.CrossRefPubMed
12.
Snyder CF, Frick KD, Herbert RJ, et al. Preventive care in prostate cancer patients: following diagnosis and for five-year survivors. J Cancer Surviv. 2011;5:283–91.PubMedCentralCrossRefPubMed
13.
14.
Salz T, Weinberger M, Ayanian JZ, et al. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Services Research. 2010;10:256.PubMedCentralCrossRefPubMed
15.
Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparison of patient and physician expectations for cancer survivorship care. J Clin Oncol. 2009;27:2489–95.CrossRefPubMed
16.
Hudson SV, Miller SM, Hemler J, et al. Adult cancer survivors discuss follow-up in primary care: ‘not what I want, but maybe what I need.’. Ann Fam Med. 2012;10:418–27.PubMedCentralCrossRefPubMed
17.
Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24:459–66.PubMedCentralCrossRef
18.
Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based sample. J Natl Cancer Inst. 2004;96:1322–30.CrossRefPubMed
19.
Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, et al. Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma. J Clin Oncol. 2007;25:4952–60.CrossRefPubMed
20.
Patnaik JL, Byers T, DiGuiseppi C, Denberg TD, Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011;103:1101–11.PubMedCentralCrossRefPubMed
21.
22.
23.
Asch SM, Sloss EM, Hogan C, Brook RH, Kravitz RL. Measuring underuse of necessary care among elderly Medicare beneficiaries using inpatient and outpatient claims. JAMA. 2000;284:2325–33.CrossRefPubMed
24.
25.
26.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMed
27.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.CrossRefPubMed
28.
Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258–67.CrossRefPubMed
29.
Rosenblatt RA, Hart LG, Baldwin L-M, Chan L, Schneeweiss R. The generalist role of specialty physicians: is there a hidden system of primary care? JAMA. 1998;279:1364–70.CrossRefPubMed
30.
Snyder CF, Frick KD, Herbert RJ, et al. Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and non-cancer controls. J Clin Oncol. 2013;31:1140–8.PubMedCentralCrossRefPubMed
31.
McDonald KM, Sundaram V, Bravata DM, et al. Closing the quality gap: a critical analysis of quality improvement strategies. Technical Review 9 (prepared by the Stanford University-UCSF Evidence-based Practice Center under contract 290-02-0017). AHRQ Publication No. 04(07)-0051-7. Rockville, MD: Agency for Healthcare Research and Quality; 2007.
32.
Sarfati D. Review of methods used to measure comorbidity in cancer populations: no gold standard exists. J Clin Epidemiol. 2012;65:924–33.CrossRefPubMed
Metadata
Title
Comorbid condition care quality in cancer survivors: role of primary care and specialty providers and care coordination
Authors
Claire F. Snyder
Kevin D. Frick
Robert J. Herbert
Amanda L. Blackford
Bridget A. Neville
Klaus W. Lemke
Michael A. Carducci
Antonio C. Wolff
Craig C. Earle
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 4/2015
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0440-4

Other articles of this Issue 4/2015

Journal of Cancer Survivorship 4/2015 Go to the issue

OriginalPaper

A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial

OriginalPaper

Evidence of altered autonomic cardiac regulation in breast cancer survivors

OriginalPaper

Physical activity and survival among Hispanic and non-Hispanic white long-term breast cancer survivors and population-based controls

OriginalPaper

Exercise training intensity prescription in breast cancer survivors: validity of current practice and specific recommendations

Review

Telephone, print, and Web-based interventions for physical activity, diet, and weight control among cancer survivors: a systematic review

Erratum

Erratum to: Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time—a population-based comparative study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits